CL2020000909A1 - Formulaciones cannabinoides sintéticas y basadas en plantas de rapido inicio y de acción prolongada. - Google Patents
Formulaciones cannabinoides sintéticas y basadas en plantas de rapido inicio y de acción prolongada.Info
- Publication number
- CL2020000909A1 CL2020000909A1 CL2020000909A CL2020000909A CL2020000909A1 CL 2020000909 A1 CL2020000909 A1 CL 2020000909A1 CL 2020000909 A CL2020000909 A CL 2020000909A CL 2020000909 A CL2020000909 A CL 2020000909A CL 2020000909 A1 CL2020000909 A1 CL 2020000909A1
- Authority
- CL
- Chile
- Prior art keywords
- synthetic
- plant
- long acting
- cannabinoid formulations
- fast onset
- Prior art date
Links
- 229930003827 cannabinoid Natural products 0.000 title abstract 2
- 239000003557 cannabinoid Substances 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 239000003623 enhancer Substances 0.000 abstract 1
- 230000035515 penetration Effects 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se describen compuestos medicinales a base de plantas de acción prolongada e inicio rápido o suplementos nutricionales y formulaciones cannabinoides sintéticas. El inicio rápido se proporciona por aminoácidos grasos N-acilados y/o potenciadores de la penetración. La acción prolongada puede proporcionarse por uno o más sistemas de liberación sostenida.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762568705P | 2017-10-05 | 2017-10-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2020000909A1 true CL2020000909A1 (es) | 2020-09-11 |
Family
ID=65992006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2020000909A CL2020000909A1 (es) | 2017-10-05 | 2020-04-03 | Formulaciones cannabinoides sintéticas y basadas en plantas de rapido inicio y de acción prolongada. |
Country Status (15)
Country | Link |
---|---|
US (1) | US20200254041A1 (es) |
EP (1) | EP3672610A4 (es) |
JP (1) | JP2020536873A (es) |
KR (1) | KR20200065009A (es) |
CN (1) | CN111225678A (es) |
AR (1) | AR113749A1 (es) |
AU (1) | AU2018345814A1 (es) |
BR (1) | BR112020006841A2 (es) |
CA (1) | CA3078549A1 (es) |
CL (1) | CL2020000909A1 (es) |
EA (1) | EA202090890A1 (es) |
IL (1) | IL273366A (es) |
MX (1) | MX2020003573A (es) |
UY (1) | UY37920A (es) |
WO (1) | WO2019071213A1 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2018012913A (es) | 2016-04-22 | 2019-01-30 | Receptor Life Sciences Inc | Compuestos medicinales y suplementos nutricionales de base vegetal de rapida accion. |
EA201892396A1 (ru) | 2016-12-02 | 2019-04-30 | Ресептор Лайф Сайенсиз, Инк. | Быстродействующие растительные лекарственные соединения и биологически активные добавки |
CA3062138A1 (en) * | 2018-08-20 | 2020-02-20 | Hexo Operations Inc. | Cannabis-infused product with enhanced cannabinoid profile user experience |
KR102415857B1 (ko) * | 2019-06-12 | 2022-07-01 | 넥타 헬스 사이언시즈 인코포레이티드 | 칸나비스로부터 표적 화합물의 선택된 패밀리를 추출, 가공, 및 정제하는 방법 |
US11622956B1 (en) | 2019-06-26 | 2023-04-11 | RCR BioPharma | Compound and method for treating diseases and disorders |
US10780075B1 (en) * | 2019-07-31 | 2020-09-22 | Etain IP, LLC | Water soluble cannabis composition |
JP2022543703A (ja) * | 2019-08-09 | 2022-10-13 | ジュピター ウェルネス, インコーポレイテッド | Cbd製剤およびその使用 |
CA3150979A1 (en) * | 2019-09-12 | 2021-03-18 | Nulixir Inc. | Controlled release core-shell particles and suspensions including the same |
BR112022007601A2 (pt) * | 2019-10-21 | 2022-10-04 | Esolate Ltd | Compostos superfinos e produção dos mesmos |
US20230023342A1 (en) * | 2019-11-12 | 2023-01-26 | London Pharmaceuticals And Research Corporation | Chewing gum containing synergistic medicinal compounds |
US20210212950A1 (en) * | 2020-01-15 | 2021-07-15 | Resurgent Pharmaceuticals, Inc. | Orally deliverable formulation to prevent all cause mortality and cardiovascular events |
CN111517980B (zh) * | 2020-05-14 | 2021-02-09 | 台州浦凯医药科技有限公司 | N-[8-(2-羟基苯甲酰基)氨基]辛酸一钾晶型化合物、制备方法及用途 |
KR102433007B1 (ko) * | 2020-07-28 | 2022-08-16 | 동의대학교 산학협력단 | 산골취 추출물을 포함하는 신경병증성 통증 예방 및 개선용 조성물 |
WO2022115973A1 (en) * | 2020-12-04 | 2022-06-09 | Nectar Health Sciences Inc. | Solvent-switching methods for precipitation, processing, and purification of selected cannabinoids from concentrated complex mixtures |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2385365A (en) * | 1943-02-17 | 1945-09-25 | Wisconsin Alumni Res Found | Salicylic acid compounds for safer therapeutic use |
DE2537232B2 (de) * | 1974-08-22 | 1976-07-01 | Spritz- und formmasse | |
BR9604880A (pt) * | 1995-03-31 | 1998-05-19 | Emisphere Tech Inc | Composto composição forma de unidade de dosagem métodos para administração de um agente biologicamente ativo para preparar uma composição para administração de um agente ativo e para preparar um composto e composição farmacológica |
DE60017888T2 (de) * | 1999-04-05 | 2006-01-19 | Emisphere Technologies, Inc. | Dinatrium-salze, monohydrate und ethanol-solvate |
CA2438097C (en) * | 2001-02-14 | 2006-04-25 | Gw Pharma Limited | Cannabinoids pharmaceutical formulations |
ES2439738T3 (es) * | 2001-04-18 | 2014-01-24 | Prometic Biosciences Inc. | Ácidos grasos de longitud de cadena media, glicéridos y análogos como factores de supervivencia y activación de neutrófilos |
WO2004056337A2 (en) * | 2002-12-18 | 2004-07-08 | Pain Therapeutics | Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats |
MXPA06006586A (es) * | 2003-12-09 | 2007-02-21 | Pharmasset Inc | Metodos de dosificacion para la terapia antiviral con beta-d-2',3'-didesoxi-2',3'-dideshidro-5-fluorocitidina. |
ES2443817T3 (es) * | 2007-11-02 | 2014-02-20 | Emisphere Technologies, Inc. | Método para tratar la deficiencia de vitamina B12 |
KR101839864B1 (ko) * | 2012-09-21 | 2018-03-20 | 인텐시티 쎄라퓨틱스, 인코포레이티드 | 암을 치료하는 방법 |
WO2015118549A1 (en) * | 2014-02-10 | 2015-08-13 | F&C Licorice Ltd. | Encapsulated biologically active agents |
WO2016022936A1 (en) * | 2014-08-07 | 2016-02-11 | Murty Pharmaceuticals, Inc. | An improved oral gastrointestinal dosage form delivery system of cannabinoids and/or standardized marijuana extracts |
EP3368014B1 (en) * | 2015-10-26 | 2023-10-04 | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd | Novel cannabinoid formulations |
IL244278A0 (en) * | 2016-02-24 | 2016-07-31 | Cannabics Pharmaceuticals Inc | An ingredient containing cannabinoids, methods for its preparation and its uses |
-
2018
- 2018-10-05 AR ARP180102890A patent/AR113749A1/es unknown
- 2018-10-05 WO PCT/US2018/054733 patent/WO2019071213A1/en unknown
- 2018-10-05 MX MX2020003573A patent/MX2020003573A/es unknown
- 2018-10-05 UY UY0001037920A patent/UY37920A/es not_active Application Discontinuation
- 2018-10-05 KR KR1020207011455A patent/KR20200065009A/ko unknown
- 2018-10-05 EP EP18865276.2A patent/EP3672610A4/en not_active Withdrawn
- 2018-10-05 CA CA3078549A patent/CA3078549A1/en not_active Abandoned
- 2018-10-05 CN CN201880060073.6A patent/CN111225678A/zh active Pending
- 2018-10-05 EA EA202090890A patent/EA202090890A1/ru unknown
- 2018-10-05 JP JP2020519349A patent/JP2020536873A/ja active Pending
- 2018-10-05 AU AU2018345814A patent/AU2018345814A1/en not_active Abandoned
- 2018-10-05 BR BR112020006841-1A patent/BR112020006841A2/pt not_active Application Discontinuation
- 2018-10-05 US US16/753,726 patent/US20200254041A1/en not_active Abandoned
-
2020
- 2020-03-17 IL IL273366A patent/IL273366A/en unknown
- 2020-04-03 CL CL2020000909A patent/CL2020000909A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AR113749A1 (es) | 2020-06-10 |
MX2020003573A (es) | 2020-08-03 |
CA3078549A1 (en) | 2019-04-11 |
EP3672610A1 (en) | 2020-07-01 |
JP2020536873A (ja) | 2020-12-17 |
UY37920A (es) | 2019-03-29 |
US20200254041A1 (en) | 2020-08-13 |
WO2019071213A1 (en) | 2019-04-11 |
CN111225678A (zh) | 2020-06-02 |
EP3672610A4 (en) | 2021-06-02 |
KR20200065009A (ko) | 2020-06-08 |
EA202090890A1 (ru) | 2020-09-03 |
AU2018345814A1 (en) | 2020-05-14 |
IL273366A (en) | 2020-05-31 |
BR112020006841A2 (pt) | 2020-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2020000909A1 (es) | Formulaciones cannabinoides sintéticas y basadas en plantas de rapido inicio y de acción prolongada. | |
CO2018011299A2 (es) | Compuestos medicinales y suplementos nutricionales de base vegetal de rápida acción | |
CL2019001471A1 (es) | Compuestos medicinales y suplementos nutricionales de base vegetal de rápida acción. | |
CL2017003404A1 (es) | Compuestos antibacterianos | |
CL2019001832A1 (es) | Compuestos medicinales y suplementos nutricionales. | |
AR096869A1 (es) | Neurotoxinas catiónicas | |
CL2018000786A1 (es) | Nuevos derivados de pirrolo[2,3-d]pirimidina, un proceso para su preparación y composiciones farmacéuticas que los contienen. | |
BR112019018036B8 (pt) | Variante de aspartoquinase inovadora e método para produzir l-aminoácido com o uso da mesma | |
CO2020005349A2 (es) | Composiciones de hierbas con mejor biodisponibilidad | |
UY37351A (es) | Complemento para el pienso | |
ECSP17059101A (es) | Composición ácida a base de leonardita y aminoácidos | |
CL2018002645A1 (es) | Sulfonamidas sustituidas para controlar plagas animales | |
CL2020000869A1 (es) | Enantiómeros de tiazoles sustituidos compuestos antivirales. | |
GB2569854B (en) | Organic compound, and light-emitting diode and light-emitting device including the same | |
EA201791716A1 (ru) | Фармацевтический состав | |
EP3331042A4 (en) | Encapsulation Material, Organic Light-emitting Device and Method of Encapsulation Therefor | |
CL2018003188A1 (es) | Procedimiento para la preparación de cuerpos moldeados para la administración a animales. | |
EA201891256A1 (ru) | Индивидуальная активация в подгруппе источников | |
NI201300090S (es) | Diseño de paleta de caramelo de personaje de chocolate m&m | |
RU2014151853A (ru) | Урбамобильная транспортная система и способ ее эксплуатации | |
ECSDI18011965S (es) | Configuración aplicada a la base de la bomba | |
UA112269U (xx) | Люмінесцентний матеріал | |
ECSDI18011966S (es) | Configuración aplicada a la taza de la bomba | |
NI201600065S (es) | Tablero para juego de mesa | |
IT201700092271A1 (it) | Composizione a base di olio essenziale di katrafay (cedrelopsis grevei) e suo uso come cosmetico, medicamento e/o integratore |